Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.

Mannell, H; Hellwig, N; Gloe, T; Plank, C; Sohn, HY; Groesser, L; Walzog, B; Pohl, U; Krötz, F

doi:10.1159/000110081

Benutzer: Gast

journal article

Titel:: Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Dokumenttyp:: Journal Article; Research Support, Non-U.S. Gov't
Autor(en):: Mannell, H; Hellwig, N; Gloe, T; Plank, C; Sohn, HY; Groesser, L; Walzog, B; Pohl, U; Krötz, F
Abstract:: Endothelial cell survival is indispensable to maintain endothelial integrity and initiate new vessel formation. We investigated the role of SHP-2 in endothelial cell survival and angiogenesis in vitro as well as in vivo. SHP-2 function in cultured human umbilical vein and human dermal microvascular endothelial cells was inhibited by either silencing the protein expression with antisense-oligodesoxynucleotides or treatment with a pharmacological inhibitor (PtpI IV). SHP-2 inhibition impaired capillary-like structure formation (p < 0.01; n = 8) in vitroas well as new vessel growth ex vivo(p < 0.05; n = 10) and in vivo in the chicken chorioallantoic membrane (p < 0.01, n = 4). Additionally, SHP-2 knock-down abrogated fibroblast growth factor 2 (FGF-2)-dependent endothelial proliferation measured by MTT reduction (p < 0.01; n = 12). The inhibitory effect of SHP-2 knock-down on vessel growth was mediated by increased endothelial apoptosis (annexin V staining, p < 0.05, n = 9), which was associated with reduced FGF-2-induced phosphorylation of phosphatidylinositol 3-kinase (PI3-K), Akt and extracellular regulated kinase 1/2 (ERK1/2) and involved diminished ERK1/2 phosphorylation after PI3-K inhibition (n = 3). These results suggest that SHP-2 regulates endothelial cell survival through PI3-K-Akt and mitogen-activated protein kinase pathways thereby strongly affecting new vessel formation. Thus, SHP-2 exhibits a pivotal role in angiogenesis and may represent an interesting target for therapeutic approaches controlling vessel growth.
Zeitschriftentitel:: J Vasc Res
Jahr:: 2008
Band / Volume:: 45
Heft / Issue:: 2
Seitenangaben Beitrag:: 153-63
Sprache:: eng
Volltext / DOI:: doi:10.1159/000110081
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/17962719
Print-ISSN:: 1018-1172
TUM Einrichtung:: Institut für Experimentelle Onkologie und Therapieforschung
BibTeX

Vorkommen:

mediaTUM Gesamtbestand Einrichtungen Schools TUM School of Medicine and Health Ehemalige Einrichtungen Institut für Experimentelle Onkologie und Therapieforschung 2008

mediaTUM Gesamtbestand Hochschulbibliographie 2008 Fakultäten Medizin Institut für Experimentelle Onkologie und Therapieforschung